Kuangli Bio-Tech Holdings Co (TPE:6431) ROCE % : -22.01% (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Kuangli Bio-Tech Holdings Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kuangli Bio-Tech Holdings Co's annualized ROCE % for the quarter that ended in Mar. 2025 was -22.01%.

Kuangli Bio-Tech Holdings Co ROCE % Historical Data

The historical data trend for Kuangli Bio-Tech Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kuangli Bio-Tech Holdings Co ROCE % Chart

Kuangli Bio-Tech Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-12.13

10.88

-7.96

-13.66

-24.45

Kuangli Bio-Tech Holdings Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															-19.89	-20.43	-15.33	-37.51	-22.01

Kuangli Bio-Tech Holdings Co ROCE % Calculation

Kuangli Bio-Tech Holdings Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-166.529	/	( ( (1043.263 - 283.107)	+	(910.202 - 307.954) )	/ 2 )
	=	-166.529	/	( (760.156	+	602.248)	/ 2 )
	=	-166.529	/	681.202
	=	-24.45 %

Kuangli Bio-Tech Holdings Co's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	-165.128	/	( ( (910.202 - 307.954)	+	(1206.583 - 308.321) )	/ 2 )
	=	-165.128	/	( ( 602.248	+	898.262 )	/ 2 )
	=	-165.128	/	750.255
	=	-22.01 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Kuangli Bio-Tech Holdings Co (TPE:6431) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Kuangli Bio-Tech Holdings Co ROCE % Related Terms

Thank you for viewing the detailed overview of Kuangli Bio-Tech Holdings Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kuangli Bio-Tech Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Kuangli Bio-Tech Holdings Co Ltd (TPE:6431) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jianguo North Road, 9th Floor, No. 66, Section. 2, Zhongshan District, Taipei, TWN, 10485

Website

https://www.kl-holdings.com

Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.

Kuangli Bio-Tech Holdings Co Headlines

No Headlines